Suma Shah is a Neurology physician affiliated with Duke University. OpenAlex indexes 52 publications with 394 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2301 Erwin Rd
Durham, NC 27705
Telephone
919-684-8111Registry record last updated 29 Aug 2018.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- EMD Serono, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
74.5%Gabapentinoids18.1%Gabapentin66%Pregabalin34%Part D<11 patientsCalcitonin gene-related peptide (CGRP) antagonists11.5%Emgality Pen75%Aimovig Autoinjector26%Part D<11 patients+ 8 more classes in this area
Musculoskeletal
15.4%gamma-Aminobutyric Acid-ergic Agonist11.5%Baclofen100%Part D≥14 patientsCentral alpha-2 Adrenergic Agonist3.9%Tizanidine Hcl100%Part D<11 patientsCancer & immunology
6.6%Sphingosine 1-phosphate Receptor Modulator6.6%Mayzent59%Fingolimod41%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Re-challenge of immune checkpoint inhibitor after ICI-encephalitis: A case report
Journal of Neuroimmunology
2026 - Rare demyelinating autoimmune diseases and pregnancy outcomes
Multiple Sclerosis and Related Disorders
2026 - The Interplay of Parental Leave, Career Achievement, and Burnout in Academic Neurologists: A Multicenter Study
Journal of Women s Health
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
Jonathan Piccini, MD
Duke University
Vance Fowler, MD
Duke University
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”